- HTG Molecular Diagnostics Inc Key Opinion Leader (KOL) “The Role of RNA Profiling in Drug Discovery and Analysis” - Corporate Call TranscriptDec 13, 2022
- Q2 2022 HTG Molecular Diagnostics Inc Earnings Call TranscriptAug 11, 2022€13.06 (+0.93%)Earnings
- HTG Molecular Diagnostics Inc Host a Key Opinion Leader (KOL) Webinar TranscriptJul 27, 2022
- Q1 2022 HTG Molecular Diagnostics Inc Earnings Call TranscriptMay 12, 2022€6.54 (-20.84%)Earnings
- Q4 2021 HTG Molecular Diagnostics Inc Earnings Call TranscriptMar 29, 2022€17.16Earnings
- Q3 2021 HTG Molecular Diagnostics Inc Earnings Call TranscriptNov 10, 2021€51.12 (-1.84%)Earnings
- Q2 2021 HTG Molecular Diagnostics Inc Earnings Call TranscriptAug 12, 2021€59.04 (-4.47%)Earnings
- Q1 2021 HTG Molecular Diagnostics Inc Earnings Call TranscriptMay 13, 2021€36.72 (-6.13%)Earnings
- Q4 2020 HTG Molecular Diagnostics Inc Earnings Call TranscriptMar 25, 2021€54.24 (-2.16%)Earnings
- Q3 2020 HTG Molecular Diagnostics Inc Earnings Call TranscriptNov 10, 2020€53.28 (+8.82%)Earnings
- Q2 2020 HTG Molecular Diagnostics Inc Earnings Call TranscriptAug 11, 2020€95.4 (+2.91%)Earnings
- Q1 2020 HTG Molecular Diagnostics Inc Earnings Call TranscriptMay 13, 2020€64.44 (+0.56%)Earnings
- Q4 2019 HTG Molecular Diagnostics Inc Earnings Call TranscriptMar 25, 2020€53.28 (-1.99%)Earnings
- HTG Molecular Diagnostics, Inc. - Special Call TranscriptDec 13, 2019
- Q3 2019 HTG Molecular Diagnostics Inc Earnings Call TranscriptNov 12, 2019€126 (-3.45%)Earnings
- HTG Molecular Diagnostics, Inc. - Special Call TranscriptOct 29, 2019
- Q2 2019 HTG Molecular Diagnostics Inc Earnings Call TranscriptAug 06, 2019€209.88 (+1.99%)Earnings
- Q1 2019 HTG Molecular Diagnostics Inc Earnings Call TranscriptMay 09, 2019€388.89 (-0.78%)Earnings
- Q4 2018 HTG Molecular Diagnostics Inc Earnings Call TranscriptMar 07, 2019€405 (+0.90%)Earnings
Q3 2019 HTG Molecular Diagnostics Inc Earnings Call Transcript
Greetings, and welcome to the HTG Molecular Diagnostics Inc. Third Quarter 2019 Earnings Call. (Operator Instructions) Please note that this conference is being recorded.
I will now turn the conference over to your host, Monique Kosse, LifeSci Advisors. Please go ahead, ma'am.
Thank you, Jerry. Earlier today, HTG released its financial results for the quarter ended September 30, 2019.
Before we begin the call, let me remind you that the company's remarks include forward-looking statements within the meaning of federal security laws, including statements regarding possible additional collaborations with pharma customers; anticipated continued growth in RUO profiling business and related revenue; expected growth in and benefit from pharma programs and collaborations; product development and commercialization activities; revenue expectations for the full year 2019; and projects expected to occur in 2020.
These forward-looking statements are subject to numerous risks and uncertainties, many of
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
![](https://static.gurufocus.com/material/money-back-guarantee.png)
![](https://static.gurufocus.com/trust_rating.png)
![](https://static.gurufocus.com/trust.png)